GenSight Biologics will participate to the 2020 North American Neuro-Ophthalmology Society (NANOS) 46thAnnual Meeting at the Omni Hotels&Resort, Amelia Island, Florida.

The 96-week results from the RESCUE&REVERSE Phase III clinical trials of GS010 will be presented by Dr. Nancy J. Newman, MD, LeoDelle Jolley Professor of Ophthalmology and Neurology at the Emory University School of Medicine in Atlanta, GA, USA. Dr. Newman is an International Principal Investigator and Site Principal Investigator of the REVERSE trial. Widely recognized as one of the leading authorities on Leber Hereditary Optic Neuropathy (LHON), Dr. Newman has been integral to defining and describing LHON pathophysiology and clinical declarations.

Bilateral Visual Improvement with Unilateral Gene Therapy for Leber Hereditary Optic Neuropathy (LHON) presented by Nancy J. Newman, MD, LeoDelle Jolley Professor of Ophthalmology and Neurology, Emory University School of Medicine, Atlanta, GA

  • Scientific Platform Session III, Amelia Ballroom
  • Tuesday, March 10, 11:00 am – 11:15 am EST